Crown Castle enters the final days of August with a striking split: options traders are the most defensively positioned they have been all year, yet short sellers are exiting the stock at their fastest pace in months.
The options signal is the loudest data point this week. The put/call ratio has climbed to near its 52-week high of 0.65, printing at 0.59 on August 25 — almost three standard deviations above its 20-day average of 0.46. That reading is not a slow drift; it is a jump that happened in two sessions, with the PCR holding below 0.47 for most of August before spiking on August 24 and again the following day. Investors are paying up for downside protection at a rate that is unusual for this name.
Short interest tells the opposite story. Estimated short interest fell 21% in a single session on August 25, dropping to 2.2% of the free float — its lowest level in the 30-day window. The week-on-week decline is 23%, and the month-on-month decline is 27%. At just over 9 million shares short against 303 million available to borrow, the borrow market is among the loosest it has been all year, with availability at 5,693% — over five times the shares borrowed still sitting in the lending pool. Cost to borrow has also eased, running at 0.39%, down 18% on the week and 21% over the past month. The lending market offers no squeeze pressure whatsoever. The contrast is clean: options traders are hedging hard, short sellers are walking away.
The Street's direction of travel is less ambiguous. Barclays upgraded CCI to Overweight on August 20 — the most recent action — but simultaneously cut its target from $92 to $84, a move that summarises the broader analyst mood neatly. Since late July, JP Morgan, Citigroup, Truist Securities, TD Cowen, and RBC Capital have all trimmed their targets, even while maintaining positive or neutral ratings. The consensus remains Hold, with a mean target of $95.07 against Tuesday's $76.29 close — implying roughly 25% upside on paper, though that gap has been narrowing steadily as targets come in. The EV/EBITDA multiple has edged up 0.11x over the past 30 days to 22.7x, and the analyst recommendation divergence factor scores in the 93rd percentile, meaning CCI's analyst-rating profile is more stretched relative to peers than almost any other name in the universe. The bull case rests on $35 million of incremental AFFO from improved operations and lower interest costs; bears point to a 5% year-on-year drop in site rental revenue and the concentration risk from three carriers accounting for 75% of revenue.
Institutional ownership is stable and index-heavy, with BlackRock (10.3%), Cohen & Steers (9.2%), and Vanguard entities combined at roughly 16% dominating the register. Lazard added 1.6 million shares in the most recent reported period — the largest incremental buy among top holders — and UBS Asset Management added 2.5 million, suggesting some active money is moving in at current levels rather than out. Closest peer AMT gained 3.6% on the week, roughly in line with CCI's 3.1%, while SBAC added 3.4%; the tower cohort has been broadly bid this week, making CCI's relative flatness more notable than the absolute gain.
The next earnings print is scheduled for October 21. After Q2 results in late July, the stock fell 2.1% the next day before recovering to gain 3.8% over the following five sessions — a pattern of initial selling absorbed by subsequent buyers. Whether options traders are positioning for a repeat of that initial dip, or anticipating something more sustained, is the question the put/call ratio raises but cannot yet answer.
See the live data behind this article on ORTEX.
Open CCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
